Guo Xiaosheng, Chen Jian, Xu Shenghui, Wang Chenyang, Hu Tianyu, Guan Qianglin, Yang Xing, Ye Jingguang, Li Xida, Sun Boyu, Yu Danqing, Dong Haojian
Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Department of Cardiology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China.
Quant Imaging Med Surg. 2024 Apr 3;14(4):2828-2839. doi: 10.21037/qims-23-1518. Epub 2024 Mar 18.
Improved coronary physiological function after percutaneous coronary intervention (PCI) has been shown to improve prognosis in stable ischaemic heart disease, but has not yet been explored in ST-segment elevated myocardial infarction (STEMI). The study sought to determine whether an improvement in the quantitative flow ratio (QFR) could improve the prognosis of STEMI patients undergoing primary PCI.
Patients diagnosed with STEMI who were receiving primary PCI were recruited for the study. Those with thrombolysis in myocardial infarction (TIMI) flow <2 after wiring were excluded. The ΔQFR was calculated using the following formula: ΔQFR = post-PCI QFR - pre-stent QFR. The primary endpoint was the composite event, including recurrent myocardial infarction (MI) and acute heart failure (AHF).
In total, 515 STEMI patients with a median follow-up of 364 days were enrolled in the study. Based on the cut-off value from the receiver operator characteristic (ROC) curve, the patients were divided into the following two groups: the lower ΔQFR group (≤0.25, N=332); and the normal ΔQFR group (>0.25, N=183). Patients with a lower ΔQFR had a relatively higher rate of MI/AHF (10.5% 4.4%, P=0.019) and AHF (7.2% 2.7%, P=0.044). A lower ΔQFR was significantly associated with a higher incidence of MI/AHF [hazard ratio (HR) =2.962, 95% confidence interval (CI): 1.358-6.459, P=0.006, respectively] after adjusting for potential confounders. Pre-stent angiographic microvascular resistance [odds ratio (OR) =1.027, 95% CI: 1.022-1.033, P<0.001] and the stent-to-vessel diameter ratio <1.13 (OR =1.766, 95% CI: 1.027-3.071, P=0.04) were independent predictors of a lower ΔQFR.
An insufficient improvement in the QFR contributes to worsening outcomes and might be a useful tool for risk stratification in STEMI.
经皮冠状动脉介入治疗(PCI)后冠状动脉生理功能的改善已被证明可改善稳定型缺血性心脏病的预后,但在ST段抬高型心肌梗死(STEMI)中尚未进行探索。本研究旨在确定定量血流比(QFR)的改善是否能改善接受直接PCI的STEMI患者的预后。
招募接受直接PCI的STEMI患者进行研究。排除导丝置入后心肌梗死溶栓(TIMI)血流<2级的患者。ΔQFR采用以下公式计算:ΔQFR = PCI术后QFR - 支架置入前QFR。主要终点是复合事件,包括复发性心肌梗死(MI)和急性心力衰竭(AHF)。
本研究共纳入515例STEMI患者,中位随访时间为364天。根据受试者工作特征(ROC)曲线的截断值,将患者分为以下两组:ΔQFR较低组(≤0.25,n = 332);ΔQFR正常组(>0.25,n = 183)。ΔQFR较低的患者MI/AHF发生率相对较高(10.5%对4.4%,P = 0.019)和AHF发生率相对较高(7.2%对2.7%,P = 0.044)。在调整潜在混杂因素后,较低的ΔQFR与MI/AHF的较高发生率显著相关[风险比(HR)= 2.962,95%置信区间(CI):1.358 - 6.459,P = 0.006]。支架置入前血管造影微血管阻力[比值比(OR)= 1.027,95% CI:1.022 - 1.033,P < 0.001]和支架与血管直径比<1.13(OR = 1.766,95% CI:1.027 - 3.071,P = 0.04)是较低ΔQFR的独立预测因素。
QFR改善不足会导致预后恶化,可能是STEMI风险分层的有用工具。